Legal & General Group PLC Exagen Inc. Transaction History

Legal & General Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$4.18 - $7.74 $3,791 - $7,020	-907 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$10.25 - $15.21 $891 - $1,323	-87 Reduced 8.75%	907 $12,000
Q2 2021 Aug 12, 2021	BUY	$12.4 - $17.92 $5,592 - $8,081	451 Added 83.06%	994 $15,000
Q1 2021 May 17, 2021	SELL	$13.9 - $22.0 $542 - $858	-39 Reduced 6.7%	543 $10,000
Q3 2020 Nov 13, 2020	SELL	$10.56 - $16.69 $2,534 - $4,005	-240 Reduced 29.2%	582 $6,000
Q2 2020 Aug 14, 2020	BUY	$11.0 - $16.7 $4,411 - $6,696	401 Added 95.25%	822 $10,000
Q1 2020 May 14, 2020	SELL	$12.7 - $25.95 $3,670 - $7,499	-289 Reduced 40.7%	421 $6,000
Q4 2019 Feb 13, 2020	BUY	$12.61 - $28.48 $8,953 - $20,220	710 New	710 $18,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $51.5M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.